Healthcare Sep 03, 2021 09:38 AM (GMT+8) · EqualOcean
Baiji Shenzhou announced that baiyueze ®( BRUKINSA ®, Zebutinib) has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients with macroglobulinemia (WM). This is bayeuser ® The second approval obtained by FDA is also the third approval of Fahrenheit macroglobulinemia worldwide.
Related companies: